SCHEMBL16005336

SCHEMBL16005336

NC1CCCC1(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28590484 0.97
SCHEMBL9483223 0.92
SCHEMBL6747441 0.78
SCHEMBL5794499 0.74
SCHEMBL5794876 0.74
SCHEMBL5794877 0.74
SCHEMBL24818785 0.72
SCHEMBL1350505 0.72
SCHEMBL16005605 0.72
Hydrochloric Acid SCHEMBL22169229 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2774915-A1 New derivatives of resveratrol Mattarei, Andrea (IT) 2014-09-10 EP claimed
CN-1333773-A Process for preparing N6-substituted deaza-adenosine derivatives AVENTIS PHARM PROD INC (US) 2002-01-30 CN claimed
WO-2014139489-A1 METHOD FOR THE PREPARATION OF TICAGRELOR AND INTERMEDIATES SUITABLE THEREFORE ZENTIVA K.S. (CZ) 2014-09-18 WO disclosed
EP-2774915-A1 New derivatives of resveratrol Mattarei, Andrea (IT) 2014-09-10 EP disclosed
CN-1122667-C Process for preparing N6-substituted deaza-adenosine derivatives AVENTIS PHARM PROD INC (US) 2003-10-01 CN disclosed
CN-1383427-A Process for preparing N6-substituted deaza-adenosine derivatives AVENTIS PHARM PROD INC (US) 2002-12-04 CN disclosed
CN-1333773-A Process for preparing N6-substituted deaza-adenosine derivatives AVENTIS PHARM PROD INC (US) 2002-01-30 CN disclosed